Showing results (661-670 of 1,810) with videos related to
Sort By:
Pageof 181
Veterinary Microbiology|December 22, 1999
Presence of the Streptococcus suis suilysin gene and expression of MRP and EF correlates with high virulence in Streptococcus suis type 2 isolatesJ J Staats, B L Plattner, G C Stewart, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1990
Hemianopic offsets in the visual field of patients with glaucomaL B Gilpin, W C Stewart, M B Shields, et al.Journal of Bacteriology|June 7, 2011
Identification of an anchor residue for CheA-CheY interactions in the chemotaxis system of Escherichia coliHemang Thakor, Sarah Nicholas, Ian M Porter, et al.Journal of Community Health|November 9, 2000
Perceived access to pediatric primary care by insurance status and raceA N Ortega, D C Stewart, S A Dowshen, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 27, 1999
The use of latanoprost 0.005% once daily and its effect on intraocular pressure as primary or adjunctive therapyS L Smith, C S Sine, C A Pruitt, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|July 1, 1995
Effect of cataract extraction on automated fields in chronic open-angle glaucomaW C Stewart, G M Rogers, C M Crinkley, et al.The Journal of Applied Bacteriology|April 1, 1993
Isolation and characterization of a Bacillus strain capable of degrading the extracellular glucan from Cellulomonas flavigena strain KUP A Bertram, C S Buller, G C Stewart, et al.Clinical Ophthalmology (Auckland, N.Z.)|December 24, 2010
Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patientsMichael J Miyashiro, Samuel C Lo, Jeanette A Stewart, et al.Brain, Behavior, and Immunity|May 7, 2009
A prospective evaluation of the directionality of the depression-inflammation relationshipJesse C Stewart, Kevin L Rand, Matthew F Muldoon, et al.Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapyJ Charles Henry, James H Peace, Jeanette A Stewart, et al.Pageof 181